Darling Ingredients
Darling Ingredients' revenue rose 7.4% to $6.1 billion in fiscal 2025. Its operating margin was 4.5%, down from 8.2% a year earlier. Free cash flow was $679 million, up 34.0%. It paid out $35 million in dividends and buybacks, 5% of free cash flow. The diluted share count fell 0.8%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2016 to 2025, earnings per share fell 5.0% a year and net income 5.3% a year, while buybacks cut the share count by 3%.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Darling Ingredients yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Darling Ingredients' 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Darling Ingredients' fiscal 2025 free cash flow of $679M, net cash of −$3.9B at January 3, 2026 and 160 million diluted shares, from its filings. The scenarios are fitted to Darling Ingredients: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, -2.1% a year, kept between 0% and 20%; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 8%: 7% for a stable business (Agricultural Products & Services), plus 1 point as a smaller company, worth $9.2B; the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $57.16
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from Darling Ingredients' earnings per share of $3.71 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 22.7×, the middle of Darling Ingredients' own P/E today, its peers' median and its sector's median (its peers' median) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 9%, 8% and 7%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $57.16
- Value at this multiple, against the last close
- —
- Darling Ingredients' P/E at the last close
- 15.4×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| DoleDOLE | $13.30 | $0.53 | 25.1× |
| Bunge GlobalBG | $102.22 | $4.29 | 23.8× |
| Archer Daniels MidlandADM | $79.01 | $3.65 | 21.6× |
| Darling IngredientsDAR | $57.16 | $3.71 | 15.4× |
| IngredionINGR | $95.43 | $9.17 | 10.4× |
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 69 | 127 | 126 | 76 | 89 |
| Debt incl. finance leases | 1,475 | 3,403 | 4,443 | 4,054 | 3,957 |
| Net debt (negative means net cash) | 1,406 | 3,276 | 4,316 | 3,978 | 3,868 |
| Net debt to EBITDA | 1.2x | 2.3x | 3.0x | 4.1x | 5.0x |
| Debt to equity | 0.5x | 0.9x | 1.0x | 0.9x | 0.8x |
| Interest coverage | 14.2x | 8.2x | 3.7x | 1.8x | 1.2x |
| Current ratio | 1.4x | 1.5x | 1.9x | 1.4x | 1.5x |
| Quick ratio | 0.8x | 0.9x | 1.1x | 0.8x | 1.0x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, 1 insider bought $60,970 of Darling Ingredients shares on the open market, and 6 insiders sold $5.3 million.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Randall C StueweChairman and CEO, Director | Sold | 5,000 | $68.20 | $341,000 | Form 4 |
| Aug 18, 2026 | Joseph ManziChief Accounting Officer | Sold | 1,000 | $67.27 | $67,270 | Form 4 |
| Aug 17, 2026 | Sandra DudleyEVP Chief Strategy Officer | Sold | 6,474 | $67.87 | $439,416 | Form 4 |
| Aug 14, 2026 | Patrick McNuttEVP Chief Admin Officer | Sold | 8,000 | $67.09 | $536,720 | Form 4 |
| Aug 13, 2026 | Randall C StueweChairman and CEO, Director | Sold | 5,000 | $64.79 | $323,950 | Form 4 |
| Aug 12, 2026 | Randall C StueweChairman and CEO, Director | Sold | 5,000 | $63.26 | $316,300 | Form 4 |
| Aug 10, 2026 | Nicholas James KemphausEVP Gen. Counsel & Secretary | Sold | 1,591 | $63.05 | $100,313 | Form 4 |
| Jul 31, 2026 | Charles L AdairDirector | Bought | 1,000 | $60.97 | $60,970 | Form 4 |
| May 1, 2026 | Joseph ManziChief Accounting Officer | Sold | 3,000 | $63.89 | $191,670 | Form 4 |
| Mar 6, 2026 | Randall C StueweChairman and CEO, Director | Sold | 20,000 | $52.12 | $1.0 million | Form 4 |
| Feb 18, 2026 | der Velden Jan vanEVP Int Rendering&Specialties | Sold | 3,000 | $51.29 | $153,870 | Form 4 |
| Feb 17, 2026 | der Velden Jan vanEVP Int Rendering&Specialties | Sold | 20,000 | $51.22 | $1.0 million | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Fail | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Pass | Fail |
| Current ratio rose | Pass | Fail | Pass |
| Share count didn't rise | Pass | Pass | Pass |
| Gross margin rose | Pass | Fail | Pass |
| Revenue rose relative to assets | Fail | Fail | Pass |
| F-score | 7 of 9 | 5 of 9 | 7 of 9 |
| Accruals ratio | −2.5% | −5.3% | −9.8% |
Compare
Put Darling Ingredients side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Darling Ingredients | FY25 | 7.4% | 4.5% | 11.1% | 3.2% | 5.0x | 7 | |
| Ingredion | FY25 | −2.8% | 14.1% | 7.1% | 16.0% | 0.6x | 8 | Compare |
| Dole | FY25 | 8.2% | 2.4% | 0.0% | 6.3% | 1.8x | 6 | Compare |
| Bunge Global | FY25 | 32.4% | — | −1.2% | 6.1% | 5.0x | 4 | Compare |
| Archer Daniels Midland | FY25 | −6.2% | — | 5.2% | 5.2% | 2.4x | 5 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 3,392 | 3,662 | 3,388 | 3,364 | 3,572 | 4,741 | 6,532 | 6,788 | 5,715 | 6,136 |
| Revenue growth | 0.0% | 8.0% | −7.5% | −0.7% | 6.2% | 32.7% | 37.8% | 3.9% | −15.8% | 7.4% |
| Gross profit | 757 | 787 | 741 | 775 | 883 | 1,242 | 1,530 | 1,645 | 1,278 | 1,474 |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | 155 | 169 | 255 | 476 | 431 | 884 | 1,029 | 950 | 468 | 273 |
| Net income | 102 | 128 | 102 | 313 | 297 | 651 | 738 | 648 | 279 | 63 |
| Diluted EPS (US$) | 0.62 | 0.77 | 0.60 | 1.86 | 1.78 | 3.90 | 4.49 | 3.99 | 1.73 | 0.39 |
| Diluted shares (millions) | 165 | 167 | 168 | 168 | 167 | 167 | 164 | 162 | 161 | 160 |
| Cash flow | ||||||||||
| Cash from operations | 391 | 410 | 399 | 363 | 625 | 704 | 814 | 899 | 839 | 1,060 |
| Capital expenditure | 244 | 274 | 322 | 360 | 280 | 274 | 391 | 556 | 332 | 380 |
| Free cash flow | 147 | 136 | 77 | 3 | 345 | 430 | 422 | 344 | 507 | 679 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 5 | 0 | 0 | 19 | 55 | 168 | 126 | 53 | 34 | 35 |
| Acquisitions | 8 | 12 | 108 | 1 | 30 | 2 | 1,772 | 1,093 | 117 | 0 |
| Stock-based compensation | 10 | 18 | 19 | 21 | 23 | 22 | 25 | 33 | 21 | 22 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 115 | 107 | 107 | 73 | 82 | 69 | 127 | 126 | 76 | 89 |
| Debt incl. finance leases | 1,775 | 1,741 | 1,697 | 1,671 | 1,524 | 1,475 | 3,403 | 4,443 | 4,054 | 3,957 |
| Total assets | 4,698 | 4,958 | 4,889 | 5,345 | 5,613 | 6,134 | 9,202 | 11,061 | 10,070 | 10,299 |
| Total liabilities | 2,622 | 2,630 | 2,554 | 2,702 | 2,659 | 2,786 | 5,306 | 6,367 | 5,606 | 5,489 |
| Shareholders' equity | 1,973 | 2,245 | 2,273 | 2,566 | 2,892 | 3,281 | 3,809 | 4,605 | 4,378 | 4,737 |
| Margins and ratios | ||||||||||
| Gross margin | 22.3% | 21.5% | 21.9% | 23.0% | 24.7% | 26.2% | 23.4% | 24.2% | 22.4% | 24.0% |
| Operating margin | 4.6% | 4.6% | 7.5% | 14.1% | 12.1% | 18.6% | 15.8% | 14.0% | 8.2% | 4.5% |
| Net margin | 3.0% | 3.5% | 3.0% | 9.3% | 8.3% | 13.7% | 11.3% | 9.5% | 4.9% | 1.0% |
| Free cash flow margin | 4.3% | 3.7% | 2.3% | 0.1% | 9.7% | 9.1% | 6.5% | 5.1% | 8.9% | 11.1% |
| Return on capital | 3.6% | 4.4% | 5.8% | 9.8% | 8.5% | 15.5% | 14.4% | 10.8% | 5.4% | 3.2% |
| Return on equity | 5.3% | 6.1% | 4.5% | 12.9% | 10.9% | 21.1% | 20.8% | 15.4% | 6.2% | 1.4% |
| Return on assets | 2.2% | 2.7% | 2.1% | 6.1% | 5.4% | 11.1% | 9.6% | 6.4% | 2.6% | 0.6% |
| Net debt to EBITDA | 3.7x | 3.5x | 2.8x | 2.0x | 1.9x | 1.2x | 2.3x | 3.0x | 4.1x | 5.0x |